News Archives - HBMC Rheumatology & Arthritis Dubai
Category

News

Best Harvard Orthopaedic Surgeon Dubai William Hodge

Exciting News: Introducing Dr. William Hodge

We are extending the warmest of welcomes to Dr. William Hodge, who we’re thrilled to announce is joining the Dr. Humeira Badsha Medical Center Family. We already know he’ll make a great addition, and we’re sure our patients will think so too!
Coming to us via Harvard; where he both worked and studied, Dr. Hodge has had an extremely compelling career to date. Traveling throughout the U.S and the Middle East, Dr. Hodge’s contributions to Orthopedics cannot be understated.
Published in a plethora of journals, with patents in several techniques and devices, he has been on the cutting edge of Musculoskeletal issues for over 40 years. Dr. Hodge is also a prestigious award winner – the height of which came when he was awarded the Ellis Island Medal of Honor in International Medicine in 2009. Prior to his nomination, this award was given to Presidents and Nobel Prize recipients.
We’re sure he will continue to do great things at Dr. Humeira Badsha Medical Center and invite you to make an appointment. Speak to an Orthopaedic Surgeon of unparalleled expertise, right here in the heart of Dubai.

View Dr. William Hodge profile: https://www.drbadshamedical.com/doctor/william-hodge/

Contact us for further information-
Dr. Humeira Badsha Medical Center
2nd Floor, Emirates Hospital, Jumeirah Road, Dubai, U.A.E.
Telephone: +9714 385 6009
Mobile: +97156 364 3215
Email: appointment@drbadshamedical.com

Dr Humeira Badsha Medical Center HBMC is moving its clinic to the Emirates Hospital - Dr. Humeira Badsha Medical Center (HBMC) is moving its clinic to the Emirates Hospital in Jumeirah, Dubai

From 2nd April 2018, Dr. Humeira Badsha Medical Center (HBMC) is moving its clinic to the Emirates Hospital in Jumeirah, Dubai. Providing the same level of excellent care as usual in a brand new location, we’re looking forward to seeing you there.

Our new address is: 2nd Floor, Emirates Hospital, Jumeirah Road, Dubai, UAE.

Contact us with any inquiries on +971 56 3643215 or email info@drbadshamedical.com

 

 

regen treatments to enhance ortho surgical outcome 1 1

Regenerative adjunctive treatment is the next logical step in the progression of surgical intervention. Biologically augmented or regenerative techniques are at the very forefront of modern treatment and have the potential to transform the practice of medicine and surgery significantly in a very short period. Less than 20 years ago, one of the first applications of platelet-rich growth factors was successfully used to help augment dental implantation.

From this starting point progressive advancements have been made, but much remains to be learned. Although the basic science remains in its infancy, especially in the areas of signaling, regulation, and mechanism, regenerative knowledge has expanded significantly in volume and across disciplines. The purpose of this review is to provide a road map of the significant developments in preclinical and clinical results involving biological solutions to improve rotator cuff, ligament, meniscus, and articular cartilage surgical repair.

A research paper on ‘Regenerative Treatments to Enhance Orthopedic Surgical Outcome’, Click to view the PDF

 

rheumatoid arthritis

Background/Purpose
Prior to the establishment of RA standards set by the ACR, a widespread discrepancy was formed between practices, which were treating patients with RA with di!erent levels of care. Thus, in order to regulate quality, the ACR implemented the following quality indicators worldwide: tuberculosis screening prior to biological disease modifying drugs (DMARDs), periodic assessment of disease activity, functional status assessment, assessment and classification of disease prognosis, glucocorticoid management, treatment with DMARDs, and follow up treatment with DMARDs.

The aim of our study was to audit our management of RA patients, and assess whether the before mentioned quality indicators were being implemented in our practice and whether this was reflected in better RA disease control.

Click to view the full article in PDF

 

rheumatoid arthritis01

Abstract

To better understand the factors that affect low disease activity (DAS28 ≤ 3.2, LDA) in rheumatoid arthritis (RA) and barriers within the UAE, demographic/ treatment data and DAS28 scores were collected through chart reviews of 182 consecutive RA patients seen at a private clinic in Dubai over a 2-month period. Patients were separated into a LDA group and a group comprised of moderate (3.2 < DAS28 < 5.1) or high disease activity (DAS28 ≥ 5.1) (MHDA). We then examined variables that may be associated with LDA and re-examined the MHDA group for barriers. While 97 (53 %) of the 182 patients had achieved the treatment target of DAS28 ≤ 3.2, 85 (47 %) had MHDA. A significantly larger portion of LDA patients had been previously treated with sulfasalazine (36 in LDA vs. 14 in MHDA, P = 0.002) or was presently on biological treatments (24 vs. 9, P = 0.013). For the 85 MHDA patients, 40 (22 % of 182) exhibited resistant disease with 25 (13.7 % of 182) failing their current first tier disease-modifying anti-rheumatic drug (DMARD) treatment or combinations and 15 (8.2 % of 182) failing current anti-TNF or biologic treatment. Reasons listed were primarily socioeconomic with 40 % of the resistant disease group unable to afford biologicals and 52 % of the patientdriven preference group discontinuing DMARDs against professional advice. Going forward, emphasis on the agreement between patient and rheumatologist on treatment, specifically regarding how DMARDs help relieve symptoms and their proper use, could help reduce the percentage of MHDA patients in the UAE.

Keywords Rheumatoid arthritis · Disease activity score · Disease control · Treat to target

Click to view the full article in PDF

 

types of lupus

Types of lupus

There can be five types of lupus:

Systemic lupus erythematosus (SLE) is the most common form and one which is referred to as “lupus“. This can affect many parts of the body In mild or serious tones. Though it’s seen mainly in women of child-bearing age, it can affect any time, in childhood or old age.
Discoid lupus erythematosus is a chronic skin disorder. Angry red rashes can appear anywhere on the body, including the face and scalp, lasting from a few days to years. with recurrence. They can become thick and scaly and cause scarring. A small percentage of people with discoid lupus have or subsequently develop SLE.
Subacute cutaneous. lupus erythematosus are skin lesions that appear on parts of the body exposed to sun. They are known to leave scars.
Drug-induced lupus is a form of lupus caused by medication. Some antlseizure and high blood pressure medication. and antibi­otics. antifungals. thyroid medication. and oral contraceptive pills are known to have indu”ced lupus. Symptoms are similar to SLE’s – arthritis. rash, fever. and chest pain – and go away completely when the drug is stopped.

Click to view the full Types of Lupus article in PDF

 

Book your appointment

Or you can simply call us